who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

Danaher Corporation (DHR) earnings date & Q3 2026 results

US GAAP · quarter ended 09/25/2026 · released Oct 21

Net earnings

$1,235M

up 36.0% y/y

Sales

$6,554M

up 8.3% y/y

Operating profit

$1,245M

up 7.9% y/y

Next report

~ Jan 27

not announced yet

The quarter in brief

Danaher's Q3 2026 sales rose 8.3% to $6,554 million and operating profit grew 7.9% to $1,245 million. Net earnings jumped 36.0% to $1,235 million, or $1.75 per diluted share versus $1.27.

Key growth driver: Q3 included $513 million of amortization of acquisition-related intangibles versus $433 million, an $84 million inventory fair value adjustment and a $52 million… · by the Q3 2026 report

All figures in $M.

Sankey diagram of DHR (Danaher Corporation) earnings report for Q3 2026: revenue, costs and profitSales$6,554 · +8.3%Cost of sales$2,717 · +7.4%Gross profit$3,837 · +8.9%58.5% marginSelling, generalandadministrativeexpenses$2,159 · +8.4%Research anddevelopmentexpenses$433 · +14.6%Operating profit$1,245 · +7.9%19.0% marginOther income(expense), net$9 · −35.7%Interest expense$135 · +101%Interest income$31 · +933%Earnings beforeincome taxes$1,132 · +5.2%Income Tax Benefit$75Earnings from discontinuedoperations, net of incometaxes$28 · vs $0Net earnings$1,235 · +36.0%$1.75/sh · 18.8% margin
Sankey diagram of DHR (Danaher Corporation) earnings report for Q3 2026: revenue, costs and profit
Line itemAmount and change
Sales$6,554 · +8.3%
Cost of sales$2,717 · +7.4%
Gross profit$3,837 · +8.9% · 58.5% margin
Selling, general and administrative expenses$2,159 · +8.4%
Research and development expenses$433 · +14.6%
Operating profit$1,245 · +7.9% · 19.0% margin
Other income (expense), net$9 · −35.7%
Interest expense$135 · +101%
Interest income$31 · +933%
Earnings before income taxes$1,132 · +5.2%
Income Tax Benefit$75
Earnings from discontinued operations, net of income taxes$28 · vs $0
Net earnings$1,235 · +36.0% · $1.75/sh · 18.8% margin

Verdict: Danaher's Q3 2026 sales rose 8.3% to $6,554 million and operating profit grew 7.9% to $1,245 million. Net earnings jumped 36.0% to $1,235 million, or $1.75 per diluted share versus $1.27.

Danaher raised its full-year 2026 adjusted diluted EPS guidance to $8.57–$8.62 from $8.45–$8.60. For Q4 2026 it expects non-GAAP core revenue excluding respiratory to grow 4.0%–5.0% and core revenue to grow about 3.0%. Q3 operating cash flow was $1.9 billion and free cash flow was $1.6 billion.

Source and notation

Source: Danaher press release, 8-K EX-99.1 of 10/21/2026 (SEC EDGAR).

Open as an image: Danaher Corporation (DHR), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “Danaher Corporation (DHR) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/dhr. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/dhr"><img src="https://whoreportstoday.com/t/dhr/img/danaher-dhr-earnings-sankey.png" alt="Danaher Corporation (DHR) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/dhr">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/dhr/img/danaher-dhr-earnings-sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/dhr">Danaher Corporation (DHR) Q3 2026 earnings chart (Who Reports Today)</a>

The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. · Text: Wikipedia, CC BY-SA 4.0, abridged

The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.

Company reports

Q3 2026latest breakdownDanaher's Q3 2026 sales rose 8.3% to $6,554 million and operating profit grew 7.9% to $1,245 million. Net earnings…
Q2 2026Better than feared — sales +5.5% to $6.27B with core growth improving to +3.0% (+4.5% excluding respiratory testing) and…

Company guidance

PeriodCompany guidanceA year agoImplied growth
FY2026EPS (non-GAAP) $8.57–8.62 (raised)revenue $24.57BEPS (GAAP) $5.05—

Same quarter a year ago (ended December 31, 2025): revenue $6.84B, EPS (GAAP) $1.69

How we calculate

EPS growth is not calculated: the guidance is non-GAAP (adjusted), while the year-ago EPS is GAAP, so the two are not comparable.

Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.

Guidance comes from the company's earnings release (Form 8-K filed Oct 21, 2026); every figure is checked against the release text.

The company's release on SEC EDGAR (8-K exhibit) ↗

DHR earnings history: past report dates

Oct 21, 2026 Wedbefore market openSep 25, 2026$6.6B+8% y/y$1.75+38% y/y
Jul 21, 2026 Tuebefore market openJun 26, 2026$6.3B+6% y/y$1.23+60% y/y
Apr 21, 2026 Tuebefore market openMar 27, 2026$6.0B+4% y/y$1.45+10% y/y
Jan 12, 2026 Mon9:07 ambefore market openDec 31, 2025≈$6.8B+5% y/y≈$1.69+13% y/y
Oct 21, 2025 Tuebefore market openSep 26, 2025$6.1B+4% y/y$1.27+13% y/y
Jul 22, 2025 Tuebefore market openJun 27, 2025$5.9B+3% y/y$0.77−37% y/y
Apr 22, 2025 Tue6:08 ambefore market openMar 28, 2025$5.7B−1% y/y$1.32−9% y/y
Jan 13, 2025 Mon4:22 pmafter market closeDec 31, 2024≈$6.5B+2% y/y≈$1.50+3% y/y
Oct 22, 2024 Tuebefore market openSep 27, 2024$5.8B+3% y/y$1.12−26% y/y
Jul 23, 2024 Tuebefore market openJun 28, 2024$5.7B−3% y/y$1.22−18% y/y
Apr 23, 2024 Tuebefore market openMar 29, 2024$5.8B−3% y/y$1.45−25% y/y
Jan 8, 2024 Mon4:22 pmafter market closeDec 31, 2023$6.4B−10% y/y$1.45−52% y/y
Oct 24, 2023 Tuebefore market openSep 29, 2023$5.6B−13% y/y$1.51−28% y/y
Show all 13 reports since 2023Show fewer
How we count

Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.

Danaher Corporation: 15-year financials

202524,5684,6903,6145,260878
202423,8754,8633,8995,296768
202323,8905,2024,7645,781821
202226,6437,5367,2097,401818
202124,8026,3776,4337,118742
202022,2844,2313,6465,417615
201917,9113,2693,0083,316527
201819,8933,0552,6513,438433
201718,3302,5722,4922,907378
201616,8822,7352,5542,932400
201514,4342,1623,3573,289354
201412,8672,0452,5983,293228
201318,2833,1212,6953,04752.1
201218,2603,1652,3922,95786.4
201116,0912,6172,1722,29261.3

$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.

* Sources
How we calculate

Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.

Danaher Corporation: 15-year balance sheet

YearAssetsEquityDebtCashCurrent assetsCurrent liabilities
202583,46452,53418,4184,61512,7566,807
202477,54249,54316,0052,0789,4976,798
202384,48853,48618,4025,86413,9378,274
202284,35050,08219,6775,99515,8838,389
202183,18445,16722,1762,58611,6488,140
202076,16139,76621,2046,03513,8027,402
201962,08230,27121,72919,91225,5964,932
201847,83328,2149,7407887,0944,842
201746,64926,35810,5226306,8504,792
201645,29523,00312,2699646,6656,874
201548,22223,69012,8707917,8376,170
201436,99223,3784,2383,0069,4315,396
201334,67222,3853,9493,1159,1144,527
201232,94119,0176,5681,6797,5884,206
201129,95016,9056,2835376,2724,172

$ millions, at fiscal year-end*.

* Sources
How we calculate

Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .

Cash flow, 8 years

YearCFO · Operating cash flowCAPEX · Capital expenditureFCF · Free cash flowcalculatedFCF margin, %calculatedDividends paidFCF / net income, %calculatedCFI · Investing cash flowCFF · Financing cash flow
20252025-12-316,416—————−1,196−2,961
20242024-12-316,688—————−1,981−8,385
20222022-12-31———————−2,570
20212021-12-31———————1,295
20182018-12-31———————−797
20172017-12-31———————−3,099
20152015-12-31———————9,050
20142014-12-31———————−218
More detailsHide details

$ millions, per fiscal year; ratios in %. “—” — no verified data or calculation not applicable.

* Sources
How we calculate

CFO, CFI and CFF are net operating, investing and financing cash flows. CAPEX is a positive cash outflow for capital expenditure; its scope follows the issuer document line. FCF = CFO − CAPEX; lease repayments are not deducted separately. If no separately sourced numeric CAPEX amount is available, CAPEX and FCF calculations are omitted. FCF margin = FCF / same-year revenue × 100. FCF / net income = FCF / same-year income attributable to shareholders × 100; losses or zero income produce a dash. Revenue and income use this card’s indicators table; missing or mismatched periods produce no ratio. Dividends and common share buybacks are actual annual cash payments from the cash flow statement, shown as positive cash outflows; payments to noncontrolling interests and share-compensation withholding taxes are excluded. Zero requires document evidence. Buybacks appear only if at least one reviewed payment exists in the fifteen-year window. The window is fifteen years; years without a single value are omitted. All listed years stay open; CFI, CFF and buybacks for Russia and Kazakhstan appear under More details.

Snapshot reviewed: . Updated after annual filings and three checks against issuer documents. Unreviewed and interim periods are excluded from the annual series.

More: latest reported period

9 months ended 2026-09-25 · $M

LineThis periodYear agoΔ
Operating cash flowcash the business generated4,7424,299+443
· incl. D&A (non-cash add-back)depreciation & amortization597555
· incl. stock-based comp (non-cash)share-based compensation266235
Capexpurchases of property & equipment−761−785+24
Free cash flow ≈operating cash flow − capex3,9813,514+467
Investing activities, netcapex, acquisitions, securities−10,696−812−9,884
· incl. acquisitionsbusinesses net of cash acquired−9,8810−9,881
Financing activities, netdebt, buybacks, dividends7,057−4,283+11,340
· incl. buybacksrepurchases of common stock−894−3,088+2,194
· incl. dividends paid−790−652−138
FX effect on cash−36246−282
Net change in cash1,067−550+1,617

Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.

Shareholders’ equity at Sep 25, 2026: $53.6B (58% of total assets). Compare with other S&P 500 companies →

Corporate governance

2/2good

  • Feb 202610-K cover: a single registered class of common stock (Common stock, $0.01), NYSE. sec.gov ↗
  • Feb 2026Diluted share count −0.4% over 2020–2025; SBC of $298M = 1.2% of revenue; buybacks of $6.0B in 2024 and $3.1B in 2025 (XBRL). data.sec.gov ↗
2 more facts and scoring

How the company treats minority shareholders: 2 — well, 0 — systematically poorly.

  • Jan 2026The quarterly dividend was raised to $0.32 per share; dividend payments of $878M in 2025 versus $768M in 2024. sec.gov ↗
  • Aug 2025Class action Hawkins v. Danaher (2023) over bioprocessing revenue guidance: the court partly denied the motion to dismiss, the case is unresolved; the 10-K lists no other shareholder suits or SEC cases. sec.gov ↗

Scoring: 2.0 with no deductions = 2.0 (single share class, no dilution, dividends rising, Hawkins suit unresolved, no SEC cases)

Share classes
Single class of common stock (10-K cover: Common stock, NYSE).
Dilution
Diluted shares −0.4% over 2020–2025 (MCPS preferred conversion included), SBC 1.2% of revenue; buybacks of $6.0B (2024) and $3.1B (2025).
Disclosure
Full 10-K/10-Q reporting.
Dividends
Quarterly dividend rising, raised to $0.32 in 2025; no cuts.
Lawsuits & regulators
Class action Hawkins v. Danaher (D.D.C., 2023) over bioprocessing guidance partly survived the motion to dismiss (Aug. 2025), unresolved → no deduction; no SEC cases.
Related parties
The Rales brothers (directors, ~10%) receive a fixed $419K salary with no bonus; agreements for servicing their aircraft on a cost-reimbursement basis — immaterial.

How the score works · checked as of Oct 2026

Included in screener lists: S&P 500 companies that paid dividends 10 years without a gap

Danaher Corporation (DHR) earnings: FAQ

When is DHR's next earnings date?

We have not yet seen an announcement of the date from Danaher Corporation (DHR). Based on last year's report on Jan 28, 2026, the next report is expected around Jan 27, 2027.

What time does DHR report earnings?

Danaher Corporation usually reports before market open: its latest results release came out on Oct 21, 2026 (the Form 8-K reached the SEC at 5:43 pm ET the evening before).

When did DHR last report earnings?

Danaher Corporation reported Q3 2026 results on Oct 21, 2026.

What has Danaher Corporation guided for FY2026?

Company guidance for FY2026: EPS (non-GAAP) $8.57–8.62 (raised). A year ago (FY2025): revenue $24.57B, EPS (GAAP) $5.05. Source: the company's earnings release (Form 8-K filed Oct 21, 2026).

Where can I find Danaher Corporation's financial statements?

On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to DHR's filings; this page breaks the latest report down in a Sankey chart.

What was DHR's net income in Q3 2026?

Danaher Corporation reported net income of $1,235M for Q3 2026 (+36.0% year over year), under US GAAP.

Does Danaher Corporation pay dividends?

Yes. In 2025, Danaher Corporation paid $878M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.

How has Danaher Corporation's revenue changed since 2011?

Per its 10-K filings, revenue grew 1.5x: $16,091M in 2011 and $24,568M in 2025. The peak was $26,643M in 2022. Year-by-year figures are in the table above.

New to earnings reports? Start with how to read an earnings report.

Get it every Monday: who reports this week

Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.

Only dates announced by companies. No stock prices. Not investment advice.

More reports: DVA · Q3 2026 · DXCM · Q3 2026 · ELV · Q3 2026 · EW · Q2 2026 · GEHC · Q3 2026 · GILD · Q3 2026 · HCA · Q3 2026 · HSIC · Q3 2026 · HUM · Q2 2026 · IDXX · Q3 2026 · all reports

Cookies the site needs and, with your consent, Google Analytics — privacy policy